Novo Holdings and TA Associates, has announced that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites.
Oxford Drug Design has been awarded £1m in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme, as announced by PACE (Pathways to Antimicrobial Clinical Efficacy).
Infex Therapeutics, an anti-infectives specialist, has announced that in collaboration with Justus-Liebig-University Giessen, it has been awarded a £1 million grant from PACE, to develop a BamA inhibitor.
Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical industries.
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.
Beckman Coulter Life Sciences along with the Indiana University School of Medicine, have been awarded a grant from the National Cancer Institute totalling $2.5 million over a five-year period to increase critical leukemia and lymphoma testing access.
Kindeva Drug Delivery’s global health security division, Meridian Medical Technologies secured a contract valued at up to $129 million to supply DuoDote, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS).
